Le Lézard
Classified in: Health
Subjects: PDT, FDA

Clarion Medical Technologies Inc. to Distribute Health Canada Approved DWP-450(prabotulinumtoxinA) in Canada


CAMBRIDGE, ON, Aug. 22, 2018 /CNW/ - Clarion Medical Technologies, a leading Canadian provider of medical and aesthetic equipment and consumables, is pleased to be the Canadian partner to Evolus, Inc.'s Health Canada approved DWP-450 (prabotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe glabellar lines (vertical lines between the eyebrows seen at maximum frown) in adult patients under 65 years of age.

Clarion Medical Technologies Inc. to Distribute Health Canada Approved DWP-450 (prabotulinumtoxinA) in Canada (CNW Group/Clarion Medical Technologies Inc.)

"The DWP-450 neurotoxin represents an exciting addition to Clarion's comprehensive aesthetic portfolio of equipment, dermal fillers, skincare and breast implants" commented Samson Ling, President and Chief Executive Officer of Clarion Medical Technologies. "We pride ourselves on offering quality aesthetic solutions to our customers and are confident that DWP-450 will provide a valuable option to physicians and consumers in 2019."

About Clarion Medical Technologies Inc.

Clarion Medical Technologies is a leading Canadian provider of medical and aesthetic equipment and consumables to hospitals, aesthetic clinics and private medical practices. The company specializes in aesthetic, otolaryngology, gynecology, urology and vision applications. Clarion Medical's strength is on harnessing the power of innovative technologies, the talents of our people and the expertise of our partners to deliver innovative solutions that improve healthcare. Products and services offered include: laser technologies, diagnostic equipment, skincare, dermal fillers, intra-ocular lenses, laser fibers, clinical education, laser safety, technical support, and regulatory and marketing services.

SOURCE Clarion Medical Technologies Inc.


These press releases may also interest you

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...

at 17:05
Sirona Biochem Corp. ("Sirona") announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024. The total number of shares represented by shareholders present in...

at 17:00
The Doctors Company, the nation's largest physician-owned medical malpractice insurer, announced today that it has approved a 2024 premium dividend of approximately $14.7 million, bringing the total of declared dividends to date to $470 million....

at 17:00
Northern Virginia Oral, Maxillofacial & Implant Surgery ("NOVA OMS") has learned of a data security incident that may have impacted data belonging to certain patients and guarantors. On October 5, 2023, NOVA OMS became aware of unusual activity on...



News published on and distributed by: